DM Meletiche - Publications, H-index & Citations

DM Meletiche

merck kgaa

3H指数

56论文数

125被引数

收录论文 15

发表时间

A DESCRIPTIVE ANALYSIS OF ICER ACCEPTANCE OF PHARMACEUTICAL MANUFACTURERS COMMENTS

VALUE IN HEALTH

IF6

2019-05-01

OAAI

Meletiche, D.; Beckerman, R.; Smith, N.; Quach, D.

IMPACT OF TIME TO REIMBURSEMENT OF DRUG TREATMENTS FOR NON-SMALL CELL LUNG ON PATIENT OUTCOMES IN EUROPE AND LATIN AMERICA

VALUE IN HEALTH

IF6

2017-10-01

OAAI

Smith, N.; Meletiche, D.; Beckerman, R.

MODELLING THE IMPACT OF PERSISTENCE IMPROVEMENTS WITH AN ELECTRONIC INJECTION DEVICE ON ESCALATION TO 2ND LINE TREATMENT IN PATIENTS WITH RELAPSING REMITTING MULTIPLE SCLEROSIS (RRMS)

VALUE IN HEALTH

IF6

2014-11-01

OAAI

Meletiche, D. M.; Rutkowski, T.; de Bustamante, Martin M. A.; Chowdhury, C. A.; Beckerman, R.

A BUDGET IMPACT ANALYSIS OF THE COCHRANE COLLABORATION REVIEW OF FIRST-LINE TREATMENTS FOR RELAPSING-REMITTIMG MULTIPLE SCLEROSIS

VALUE IN HEALTH

IF6

2014-05-01

OAAI

Meletiche, D. M.; Park, S.; Rutkowski, T.; Chowdhury, C. A.; Beckerman, R.

COMPARISON OF IN VITRO FERTILIZATION TRENDS AMONG INSURED PATIENTS IN MANAGED CARE IN THE UNITED STATES; COMPARISON OF STATES WITH AND WITHOUT MANDATED COMPREHENSIVE FERTILITY COVERAGE

VALUE IN HEALTH

IF6

2011-05-01

OAAI

Fincher, C.; Kozma, C.; Hubbard, J.; Meletiche, D. M.; Velez, F. F.

FIRST USE OF DISEASE-MODIFYING DRUGS IN PATIENTS WITH MULTIPLE SCLEROSIS

VALUE IN HEALTH

IF6

2009-05-01

OAAI

Meletiche, D. M.; Kozma, C.; Dickson, M.

COMPARISON OF COSTS FOR INTERFERON BETA 1-A AND NATALIZUMAB IN PATIENTS WITH MULTIPLE SCLEROSIS

VALUE IN HEALTH

IF6

2009-05-01

OAAI

Kozma, C.; Dickson, M.; Meletiche, D. M.

Association of measures of medication adherence and severe relapses with multiple sclerosis disease-modifying therapy

VALUE IN HEALTH

IF6

2008-05-01

OAAI

Dickson, M.; Kozma, C.; Okuda, D. T.; Fincher, C.; Meletiche, D.

Relationship between gaps in drugtreatment for multiple sclerosis and incidence of exacerbations: Findings from a national managed care database

VALUE IN HEALTH

IF6

2008-05-01

OAAI

Okuda, D. T.; Kozma, C.; Dickson, M.; Meletiche, D.

The cost of disability and medically-related absenteeism among employees with multiple sclerosis

VALUE IN HEALTH

IF6

2008-05-01

OAAI

Birnbaum, H. G.; Ivanova, J. I.; Samuels, S.; Davis, M.; Phillips, A. L.; Meletiche, D.

Comparison of compliance and persistence with immunomodulating agents for multiple sclerosis in a commercially insured population

VALUE IN HEALTH

IF6

2008-05-01

OAAI

Shea, T.; Wood, F.; Shim, B.; Becker, E.; Meletiche, D.; Bennett, R.; AL-Sabbagh, A.

Modeling treating multiple sclerosis with disease modifying drugs using discrete event simulation

VALUE IN HEALTH

IF6

2007-11-01

OAAI

Guo, S.; Copur, D.; Ward, A.; Bennett, R.; Al-Sabbah, A.; Meletiche, D. M.; Caro, J. J.

Modeling the clinical and economic consequences of treating relapsing form of multiple sclerosis with subcutaneous versus intramuscular interferon-Beta-Ia

VALUE IN HEALTH

IF6

2007-11-01

OAAI

Guo, S.; Copur, D.; Ward, A.; O'Brien, J. A.; Ishak, K. J.; Bennett, R.; Al-Sabbah, A.; Meletiche, D. M.; Caro, J. J.

Cost-effectiveness of atypical antipsychotics in the treatment of acute mania

VALUE IN HEALTH

IF6

2006-05-01

OAAI

Meletiche, DM; Meyer, K; Franklin, M; Poston, S; Grogg, A

Health care resource utilization and cost of bipolar I disorder with and without psychotic symptoms

VALUE IN HEALTH

IF6

2006-05-01

OAAI

Poston, S; Kozma, C; Meletiche, DM

研究方向